ProNGF mediates death of Natural Killer cells through activation of the p75NTR-sortilin complex

Journal of Neuroimmunology

Volumn 226, Issue 1-2, 2010, Pages 93-103

  Rogers, Mary Louise ^a   Bailey, Sheree ^a,b   Matusica, Dusan ^a   Nicholson, Ian ^c   Muyderman, Hakan ^a   Pagadala, Promila C ^d   Neet, Kenneth E ^d   Zola, Heddy ^c   Macardle, Peter ^a,b   Rush, Robert A ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b SA PATHOLOGY   (Australia)

^c Women's and Children's Health Research Institute   (Australia)

^d ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Apoptosis; Natural Killer (NK) cells; ProNGF (pro nerve growth factor); Sortilin; TNFRSF (tumor necrosis factor receptor super family)

Indexed keywords

INTERLEUKIN 12; NERVE GROWTH FACTOR; NEUROTENSIN; NEUROTROPHIN RECEPTOR INTERACTING MAGE HOMOLOGUE; NEUROTROPHIN RECEPTOR P75; SORTILIN; UNCLASSIFIED DRUG; LEUKOCYTE ANTIGEN; MESSENGER RNA; NERVE GROWTH FACTOR RECEPTOR; NERVE PROTEIN; NGFR PROTEIN, HUMAN; PRO-NERVE GROWTH FACTOR, HUMAN; PROTEIN PRECURSOR; PROTEIN TYROSINE KINASE A; VESICULAR TRANSPORT ADAPTOR PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; CLASSIFICATION; DRUG EFFECTS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; LYMPHOCYTE; METABOLISM; PROCEDURES;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANTIGENS, CD; APOPTOSIS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTES; NERVE GROWTH FACTOR; NERVE TISSUE PROTEINS; PROTEIN PRECURSORS; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; RNA, MESSENGER;

EID: 77956340615     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.05.040     Document Type: Article

References (57)

1. Aloe L., Simone M.D., Properzi F. Nerve growth factor: a neurotrophin with activity on cells of the immune system. Microsc. Res. Tech. 1999, 45:285-291.
2. Baltz K.M., Krusch M., Baessler T., Schmiedel B.J., Bringmann A., Brossart P., Salih H.R. Neutralization of tumor-derived soluble glucocorticoid-induced TNFR-related protein ligand increases NK cell anti-tumor reactivity. Blood 2008, 112:3735-3743.
3. Barouch R., Kazimirsky G., Appel E., Brodie C. Nerve growth factor regulates TNF-alpha production in mouse macrophages via MAP kinase activation. J. Leukocyte Biol. 2001, 69:1019-1026.
4. Bhakar A.L., Howell J.L., Paul C.E., Salehi A.H., Becker E.B., Said F., Bonni A., Barker P.A. Apoptosis induced by p75NTR overexpression requires Jun kinase-dependent phosphorylation of Bad. J. Neurosci. 2003, 23:11,373-11,381.
5. Blochl A., Blochl R. A cell-biological model of p75NTR signaling. J. Neurochem. 2007, 102:289-305.
6. Boyle M.D., Lawman M.J., Gee A.P., Young M. Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J. Immunol. 1985, 134:564-568.
7. Brann A.B., Tcherpakov M., Williams I.M., Futerman A.H., Fainzilber M. Nerve growth factor-induced p75-mediated death of cultured hippocampal neurons is age-dependent and transduced through ceramide generated by neutral sphingomyelinase. J. Biol. Chem. 2002, 277:9812-9818.
8. Brodie C., Gelfand E. Functional nerve growth factor receptors on human B lymphocytes. Interaction with IL-2. J. Immunol. 1992, 148:3492-3497.
9. Bronfman F.C., Tcherpakov M., Jovin T.M., Fainzilber M. Ligand-induced internalization of the p75 neurotrophin receptor: a slow route to the signaling endosome. J. Neurosci. 2003, 23:3209-3220.
10. Bronfman F.C., Escudero C.A., Weis J., Kruttgen A. Endosomal transport of neurotrophins: roles in signaling and neurodegenerative diseases. Dev. Neurobiol. 2007, 67:1183-1203.
11. Bruno M.A., Cuello A.C. Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc. Natl. Acad. Sci. USA 2006, 103:6735-6740.
12. Chao M., Casaccia-Bonnefil P., Carter B., Chittka A., Kong H., Yoon S.O. Neurotrophin receptors: mediators of life and death. Brain Res. Rev. 1998, 26:295-301.
13. Ehrhard P.B., Ganter U., Stalder A., Bauer J., Otten U. Expression of functional trk protooncogene in human monocytes. Proc. Natl. Acad. Sci. USA 1993, 90:5423-5427.
14. Fahnestock M. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol. Cell. Neurosci. 2001, 18:210-220.
15. Fauchais A.L., Lalloue F., Lise M.C., Boumediene A., Preud'homme J.L., Vidal E., Jauberteau M.O. Role of endogenous brain-derived neurotrophic factor and sortilin in B cell survival. J. Immunol. 2008, 181:3027-3038.
16. Gandhi R., Laroni A., Weiner H.L. Role of the innate immune system in the pathogenesis of multiple sclerosis. J. Neuroimmunol. 2009, 221:7-14.
17. Gee A.P., Boyle M.D., Munger K.L., Lawman M.J., Young M. Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc. Natl. Acad. Sci. USA 1983, 80:7215-7218.
18. Gurney A.L., Marsters S.A., Huang R.M., Pitti R.M., Mark D.T., Baldwin D.T., Gray A.M., Dowd A.D., Brush A.D., Heldens A.D., Schow A.D., Goddard A.D., Wood W.I., Baker K.P., Godowski P.J., Ashkenazi A. Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr. Biol. 1999, 9:215-218.
19. Jansen P., Giehl K., Nyengaard J.R., Teng K., Lioubinski O., Sjoegaard S.S., Breiderhoff T., Gotthardt M., Lin F., Eilers A., Petersen C.M., Lewin G.R., Hempstead B.L., Willnow T.E., Nykjaer A. Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury. Nat. Neurosci. 2007, 10:1449-1457.
20. Jutel M., Watanabe T., Klunker S., Akdis M., Thomet O.A., Malolepszy J., Zak-Nejmark T., Koga R., Kobayashi T., Blaser K., Akdis C.A. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001, 413:420-425.
21. Kahle P., Barker P.A., Shooter E.M., Hertel C. p75 nerve growth factor receptor modulates p140trkA kinase activity, but not ligand internalization, in PC12 cells. J. Neurosci. Res. 1994, 38:599-606.
22. Kannan Y., Ushio H., Koyama H., Okada M., Oikawa M., Yoshihara T., Kaneko M., Matsuda H. 2.5S nerve growth factor enhances survival, phagocytosis, and superoxide production of murine neutrophils. Blood 1991, 77:1320-1325.
23. Kannan Y., Matsuda H., Ushio H., Kawamoto K., Shimada Y. Murine granulocyte-macrophage and mast cell colony formation promoted by nerve growth factor. Int. Arch. Allergy Immunol. 1993, 102:362-367.
24. Kashii Y., Giorda R., Herberman R.B., Whiteside T.L., Vujanovic N.L. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J. Immunol. 1999, 163:5358-5366.
25. Kennedy S.A., van Diepen A.C., van den Hurk C.M., Coates L.C., Lee T.W., Ostrovsky L.L., Miranda E., Perez J., Davies M.J., Lomas D.A., Dunbar P.R., Birch N.P. Expression of the serine protease inhibitor neuroserpin in cells of the human myeloid lineage. Thromb. Haemost. 2007, 97:394-399.
26. Kobayashi H., Gleich G.J., Butterfield J.H., Kita H. Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood 2002, 99:2214-2220.
27. Kwon B., Yu K.Y., Ni J., Yu G.L., Jang I.K., Kim Y.J., Xing L., Liu D., Wang S.X., Kwon B.S. Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand. J. Biol. Chem. 1999, 274:6056-6061.
28. Lee R., Kermani P., Teng K.K., Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science 2001, 294:1945-1948.
29. LeSauteur L., Maliartchouk S., Le Jeune H., Quirion R., Saragovi H.U. Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody. J. Neurosci. 1996, 16:1308-1316.
30. Lin B.Z., Pilch P.F., Kandror K.V. Sortilin is a major protein component of Glut4-containing vesicles. J. Biol. Chem. 1997, 272:24,145-24,147.
31. Marano N., Dietzschold B., Earley J.J., Schatteman G., Thompson S., Grob P., Ross A.H., Bothwell M., Atkinson B.F., Koprowski H. Purification and amino terminal sequencing of human melanoma nerve growth factor receptor. J. Neurochem. 1987, 48:225-232.
32. Martin S., Vincent J.P., Mazella J. Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. J. Neurosci. 2003, 23:1198-1205.
33. Matsuda H., Kannan Y., Ushio H., Kiso Y., Kanemoto T., Suzuki H., Kitamura Y. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J. Exp. Med. 1991, 174:7-14.
34. Mazella J., Zsurger N., Navarro V., Chabry J., Kaghad M., Caput D., Ferrara P., Vita N., Gully D., Maffrand J.P., Vincent J.P. The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J. Biol. Chem. 1998, 273:26,273-26,276.
35. Melamed I., Kelleher C.A., Franklin R.A., Brodie C., Hempstead B., Kaplan D., Gelfand E.W. Nerve growth factor signal transduction in human B lymphocytes is mediated by gp140trk. Eur. J. Immunol. 1996, 26:1985-1992.
36. Morinville A., Martin S., Lavallee M., Vincent J.P., Beaudet A., Mazella J. Internalization and trafficking of neurotensin via NTS3 receptors in HT29 cells. Int. J. Biochem. Cell Biol. 2004, 36:2153-2168.
37. Morris N.J., Ross S.A., Lane W.S., Moestrup S.K., Petersen C.M., Keller S.R., Lienhard G.E. Sortilin is the major 110-kDa protein in GLUT4 vesicles from adipocytes. J. Biol. Chem. 1998, 273:3582-3587.
38. Munck Petersen C., Nielsen M.S., Jacobsen C., Tauris J., Jacobsen L., Gliemann J., Moestrup S.K., Madsen P. Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding. EMBO J. 1999, 18:595-604.
39. Nassenstein C., Mohring U.H., Luttmann W., Virchow J.C., Braun A. Differential expression of the neurotrophin receptors p75NTR, TrkA, TrkB and TrkC in human peripheral blood mononuclear cells. Exp. Toxicol. Pathol. 2006, 57(Suppl 2):55-63.
40. Naume B., Gately M., Espevik T. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. J. Immunol. 1992, 148:2429-2436.
41. Navarro V., Martin S., Sarret P., Nielsen M.S., Petersen C.M., Vincent J., Mazella J. Pharmacological properties of the mouse neurotensin receptor 3. Maintenance of cell surface receptor during internalization of neurotensin. FEBS Lett. 2001, 495:100-105.
42. Nyborg A.C., Ladd T.B., Zwizinski C.W., Lah J.J., Golde T.E. Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel gamma-secretase substrates. Mol. Neurodegener. 2006, 1:3.
43. Nykjaer A., Lee R., Teng K.K., Jansen P., Madsen P., Nielsen M.S., Jacobsen C., Kliemannel M., Schwarz E., Willnow T.E., Hempstead B.L., Petersen C.M. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004, 427:843-848.
44. Nykjaer A., Willnow T.E., Petersen C.M. p75NTR-live or let die. Curr. Opin. Neurobiol. 2005, 15:49-57.
45. Otten U., Ehrhard P., Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc. Natl. Acad. Sci. USA 1989, 86:10,059-10,063.
46. Pagadala P.C., Dvorak L.A., Neet K.E. Construction of a mutated pro-nerve growth factor resistant to degradation and suitable for biophysical and cellular utilization. Proc. Natl. Acad. Sci. USA 2006, 103:17,939-17,943.
47. Petersen C.M., Nielsen M.S., Nykjaer A., Jacobsen L., Tommerup N., Rasmussen H.H., Roigaard H., Gliemann J., Madsen P., Moestrup S.K. Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. J. Biol. Chem. 1997, 272:3599-3605.
48. Poggi A., Massaro A.-M., Negrini S., Contini P., Zocchi M.R. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors. J. Immunol. 2005, 174:2653-2660.
49. Rogers M.L., Atmosukarto I., Berhanu D.A., Matusica D., Macardle P., Rush R.A. Functional monoclonal antibodies to p75 neurotrophin receptor raised in knockout mice. J. Neurosci. Meth. 2006, 158:109-120.
50. Ross M.E., Caligiuri M.A. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 1997, 89:910-918.
51. Ross A.H., Grob P., Bothwell M., Elder D.E., Ernst C.S., Marano N., Ghrist B.F., Slemp C.C., Herlyn M., Atkinson B., et al. Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. Proc. Natl. Acad. Sci. USA 1984, 81:6681-6685.
52. Salehi A.H., Roux P.P., Kubu C.J., Zeindler C., Bhakar A., Tannis L.L., Verdi J.M., Barker P.A. NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron 2000, 27:279-288.
53. Schweigreiter R. The dual nature of neurotrophins. Bioessays 2006, 28:583-594.
54. Teng H.K., Teng K.K., Lee R., Wright S., Tevar S., Almeida R.D., Kermani P., Torkin R., Chen Z.Y., Lee F.S., Kraemer R.T., Nykjaer A., Hempstead B.L. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 2005, 25:5455-5463.
55. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat. Immunol. 2008, 9:503-510.
56. Willnow T.E., Petersen C.M., Nykjaer A. VPS10P-domain receptors - regulators of neuronal viability and function. Nat. Rev. Neurosci. 2008, 9:899-909.
57. Zingoni A., Sornasse T., Cocks B.G., Tanaka Y., Santoni A., Lanier L.L. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J. Immunol. 2004, 173:3716-3724.